Harriet Howard

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

Philip M Polly Craig S Jason P Evind Lesley Mark Timothy Bath Scutt Anderson Appleton Berge Cala Dixon Engl, P. Bath, Polly Scutt, C. Anderson +415 more

2019The Lancet155 citations Open access

Semantic Scholar

Harriet Howard

Most-cited papers

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053)

RAPID INTERVENTION WITH GLYCERYL TRINITRATE IN HYPERTENSIVE STROKE TRIAL-2 (RIGHT-2): SAFETY AND EFFICACY OF TRANSDERMAL GLYCERYL TRINITRATE, A NITRIC OXIDE DONOR

Blood transfusion and management of acute heavy menstrual bleeding (BROWNIE): a retrospective and observational cost analysis service evaluation

Consent procedures and relationship with outcome in the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2)

Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS)

P67 Audit of mycoplasma genitalium management: challenges in a London clinic

Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2): safety and efficacy of transdermal glyceryl trinitrate, a nitric oxide donor, and of the feasibility of a multicentre ambulance-based stroke trial

Abstract TP69: Baseline Characteristics and Outcomes of Stroke Mimics in The Rapid Intervention With Glyceryl Trinitrate In Hypertensive Stroke Trial-2 (RIGHT-2): An Interim Analysis